Illumina, Chinese firm forge molecular Dx collaboration

04/22/2013 | GenomeWeb Daily News (free registration)

Illumina has entered a molecular diagnostics partnership with Kindstar Global, a provider of testing services in China. The deal calls for the companies to launch molecular diagnostic assays that use Illumina's TruSight sets for next-generation sequencing, NuPCR reagents for qPCR and the Infinium Dx CytoSNP-12 BeadChip test at Kindstar's laboratories.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC